Prethrombotic state due to hypercoagulability in patients with permanent transvenous pacemakers. 1997

T Ito, and J Tanouchi, and J Kato, and M Nishino, and K Iwai, and H Tanahashi, and M Hori, and Y Yamada, and T Kamada
Division of Cardiology, Osaka Rosai Hospital, Japan.

Venous thrombosis is a relatively usual but serious complication of permanent transvenous pacing. However, the pathogenesis has not been defined. To clarify underlying abnormalities in the coagulation-fibrinolysis system in patients with permanent transvenous pacemakers, we measured serum levels of fibrinopeptide A (FPA), thrombin-antithrombin III complexes (TATs), plasmin-alpha 2 plasmin inhibitor complexes (PICs), D-dimer (D-D), beta-thromboglobulin (beta-TG), and platelet factor 4 (PF4) in 53 patients with permanent transvenous pacemakers and 10 control subjects. The patients were divided into two groups, as follows, according to the presence of mural thrombus documented along the pacing lead(s) by digital subtraction angiography and transesophageal echocardiography: Group Th (-), patients without venous route thrombus; and Group Th (+), patients with venous route thrombus. FPA and TAT levels increased significantly even in Group Th (-), and further increased in Group Th (+) compared with control subjects (FPA: 7.5 +/- 4.9, 15.3 +/- 8.8 vs 3.0 +/- 1.4 ng/mL, respectively, P < 0.05; TAT: 2.9 +/- 1.3, 4.8 +/- 2.3 vs 1.7 +/- 0.6 ng/mL, respectively, P < 0.05). There were no differences in levels of D-D, PIG, beta-TG, and PF4 among control subjects, Group Th (-), and Group Th (+). These findings suggest that the hypercoagulable state appears in patients with permanent transvenous pacemakers, even without apparent venous thrombosis. The patients with permanent transvenous pacemakers are thought to be in the prethrombotic state even if they have no venous route thrombosis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010138 Pacemaker, Artificial A device designed to stimulate, by electric impulses, contraction of the heart muscles. It may be temporary (external) or permanent (internal or internal-external). Cardiac Pacemaker, Artificial,Artificial Cardiac Pacemaker,Artificial Cardiac Pacemakers,Artificial Pacemaker,Artificial Pacemakers,Cardiac Pacemakers, Artificial,Pacemaker, Artificial Cardiac,Pacemakers, Artificial,Pacemakers, Artificial Cardiac
D010447 Peptide Hydrolases Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES. Peptidase,Peptidases,Peptide Hydrolase,Protease,Proteases,Proteinase,Proteinases,Proteolytic Enzyme,Proteolytic Enzymes,Esteroproteases,Enzyme, Proteolytic,Hydrolase, Peptide
D010978 Platelet Factor 4 A CXC chemokine that is found in the alpha granules of PLATELETS. The protein has a molecular size of 7800 kDa and can occur as a monomer, a dimer or a tetramer depending upon its concentration in solution. Platelet factor 4 has a high affinity for HEPARIN and is often found complexed with GLYCOPROTEINS such as PROTEIN C. Antiheparin Factor,CXCL4 Chemokine,Chemokine CXCL4,Heparin Neutralizing Protein,PF4 (Platelet Factor 4),gamma-Thromboglobulin,CXCL4, Chemokine,Chemokine, CXCL4,gamma Thromboglobulin
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D002304 Cardiac Pacing, Artificial Regulation of the rate of contraction of the heart muscles by an artificial pacemaker. Pacing, Cardiac, Artificial,Artificial Cardiac Pacing,Artificial Cardiac Pacings,Cardiac Pacings, Artificial,Pacing, Artificial Cardiac,Pacings, Artificial Cardiac
D005260 Female Females
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin

Related Publications

T Ito, and J Tanouchi, and J Kato, and M Nishino, and K Iwai, and H Tanahashi, and M Hori, and Y Yamada, and T Kamada
March 1970, New York state journal of medicine,
T Ito, and J Tanouchi, and J Kato, and M Nishino, and K Iwai, and H Tanahashi, and M Hori, and Y Yamada, and T Kamada
January 1975, The Journal of thoracic and cardiovascular surgery,
T Ito, and J Tanouchi, and J Kato, and M Nishino, and K Iwai, and H Tanahashi, and M Hori, and Y Yamada, and T Kamada
November 1974, British heart journal,
T Ito, and J Tanouchi, and J Kato, and M Nishino, and K Iwai, and H Tanahashi, and M Hori, and Y Yamada, and T Kamada
February 1992, Kokyu to junkan. Respiration & circulation,
T Ito, and J Tanouchi, and J Kato, and M Nishino, and K Iwai, and H Tanahashi, and M Hori, and Y Yamada, and T Kamada
July 1980, Pacing and clinical electrophysiology : PACE,
T Ito, and J Tanouchi, and J Kato, and M Nishino, and K Iwai, and H Tanahashi, and M Hori, and Y Yamada, and T Kamada
July 1977, The Journal of thoracic and cardiovascular surgery,
T Ito, and J Tanouchi, and J Kato, and M Nishino, and K Iwai, and H Tanahashi, and M Hori, and Y Yamada, and T Kamada
January 1997, Srpski arhiv za celokupno lekarstvo,
T Ito, and J Tanouchi, and J Kato, and M Nishino, and K Iwai, and H Tanahashi, and M Hori, and Y Yamada, and T Kamada
November 1967, American journal of surgery,
T Ito, and J Tanouchi, and J Kato, and M Nishino, and K Iwai, and H Tanahashi, and M Hori, and Y Yamada, and T Kamada
August 1968, The Journal of the Kentucky Medical Association,
T Ito, and J Tanouchi, and J Kato, and M Nishino, and K Iwai, and H Tanahashi, and M Hori, and Y Yamada, and T Kamada
December 2016, Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology,
Copied contents to your clipboard!